Clinical Trials Logo

Hidradenitis Suppurativa clinical trials

View clinical trials related to Hidradenitis Suppurativa.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT03661866 Not yet recruiting - Psoriasis Clinical Trials

A 5-year Study of Patients Treated for Atopic Dermatitis and Other IMISC

TARGET-DERM
Start date: October 1, 2018
Phase:
Study type: Observational [Patient Registry]

TARGET-DERM is a 5-year, longitudinal, observational study of adult and pediatric patients being managed for Atopic Dermatitis and other Immune-Mediated Inflammatory Skin Conditions (IMISC) in usual clinical practice. TARGET-DERM will create a research registry of patients with IMISC within academic and community real-world practices in order to assess the safety and effectiveness of current and future therapies.

NCT ID: NCT03221621 Not yet recruiting - Clinical trials for Hidradenitis Suppurativa

Cost-effectiveness of Adalimumab and Surgery vs Adalimumab in HS

HS-COST
Start date: August 1, 2017
Phase: Phase 4
Study type: Interventional

The primary objective of this randomized controlled clinical trial in a real life setting is to evaluate the cost-utility of limumab monotherapy compared with the combination of adalimumab and a maximum of three surgeries after two years of treatment in adult patients with moderate to severe HS.